Cord Blood Banking Services Market

Cord Blood Banking Services Market Size and Share:

The global cord blood banking services market size was valued at USD 2.02 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 4.57 Billion by 2033, exhibiting a CAGR of 9.02% during 2025-2033. North America currently dominates the market, holding a significant market share of over 33.8% in 2024. The market is growing due to rising awareness about stem cell therapies, increasing prevalence of genetic disorders, advancements in regenerative medicine, government initiatives, and growing adoption of private banking. Moreover, the improved storage technologies, rising healthcare expenditure, expanding research applications, and increasing childbirth rates in key regions are some of the other factors fueling the cord blood banking services market share.

The market is driven by increasing awareness of stem cell therapies and their potential in treating over 80 diseases, including leukemia, lymphoma, and autoimmune disorders. Rising prevalence of genetic diseases and growing demand for regenerative medicine are major contributors. The expansion of private cord blood banks is fueled by higher disposable incomes, personalized healthcare trends, and exclusive stem cell storage services. Government initiatives, regulatory approvals, and funding for public cord blood banks further support market growth. Technological advancements in cryopreservation, automation, and stem cell processing enhance service efficiency. Additionally, increasing birth rates, growing clinical trials, and research in novel stem cell applications creating a positive cord blood banking services market outlook.

The market for cord blood banking services in the United States is driven by high awareness of stem cell therapies, increasing prevalence of genetic and blood disorders, and strong government support for regenerative medicine research. The presence of advanced healthcare infrastructure, well-established private and public banking systems, and stringent FDA regulations ensures market stability. Growing adoption of private cord blood banking is fueled by rising disposable incomes, personalized medicine trends, and parental concerns over future medical needs. Technological advancements in cryopreservation and automated stem cell processing further enhance service quality. Expanding clinical trials and FDA-approved stem cell treatments for conditions like leukemia, cerebral palsy, and diabetes also drive the cord blood banking services demand. Additionally, corporate partnerships, hospital collaborations, and insurance-backed banking services support market growth. For instance, in September 2023, CooperSurgical, a leading fertility and women's health company worldwide, said that the Cord Blood Registry (CBR) was a vital part of the Cord Blood Connect meeting, which was held from September 8th to September 11th and was the annual meeting of the Cord Blood Association. The global non-profit Cord Blood Association promotes the quick use of cord blood and birthing tissues for patient benefit and medical advancement, as well as the preservation of both public and family newborn stem cells.

Cord Blood Banking Services Market Trends:

Rising Awareness about Stem Cell Therapies

The increasing knowledge of cord blood’s potential in treating over 80 diseases, including leukemia, lymphoma, and immune disorders, is a key driver of the market. By 2025, an estimated 22,010 Americans will receive a diagnosis of acute myeloid leukemia (AML), according to the American Cancer Society. The majority of cases will involve adults. 11,090 people will lose their lives to AML. Once more, the majority of these fatalities will occur in adults. Awareness campaigns by government bodies, private banks, and healthcare institutions are encouraging more parents to preserve their newborn’s stem cells for potential future use. Medical advancements in regenerative medicine and stem cell transplantation further emphasize the importance of cord blood storage. Educational efforts by organizations such as the Cord Blood Association and National Marrow Donor Program are also playing a crucial role in boosting public and healthcare professional awareness about the benefits of cord blood banking.

Growing Prevalence of Genetic and Autoimmune Disorders

The increasing incidence of genetic, blood-related, and autoimmune disorders is driving demand for cord blood stem cell banking services. Conditions such as sickle cell anemia, thalassemia, and metabolic disorders are becoming more common, prompting parents to store cord blood as a precautionary measure. According to industry reports, an estimated 300,000 to 400,000 children are born with severe hemoglobinopathies every year as a result of the 5.2% of the world's population having hemoglobin abnormalities. 4.4 out of every 10,000 live newborns are affected by thalassemia, a hereditary hemoglobinopathy that is more prevalent in Africa, the Middle East, southern China, Southeast Asia, and Mediterranean coastal regions. Additionally, researchers are exploring the potential of cord blood-derived mesenchymal stem cells (MSCs) for regenerative medicine, including treatments for diabetes, cerebral palsy, and neurodegenerative diseases. As clinical applications expand, more families are opting for private cord blood banking, fueling market growth and investment in long-term cryopreservation technologies.

Technological Advancements in Cryopreservation and Stem Cell Processing

Advancements in cryopreservation, automated processing, and stem cell expansion technologies are enhancing the efficiency and viability of stored cord blood samples. Innovations in cord blood collection, storage, and thawing techniques ensure that stem cells remain functional for decades, increasing consumer confidence. Automated cell separation, AI-driven sample tracking, and biorepository management systems are improving service reliability and regulatory compliance. Additionally, advancements in genetic screening and personalized medicine are enabling researchers to develop targeted therapies using stored cord blood, making cord blood banking more appealing to families seeking future-proof medical solutions. For instance, in July 2024, The NMDP BioTherapies Cord Blood Bank Alliance (CBBA), a partnership between NMDP BioTherapies and nine public cord blood banks, and NMDP BioTherapiesSM, a leader in cell and gene therapy development support, are making pre-identified cord blood units optimized to produce cord-derived cell therapies, specifically cord-derived NK cell therapies, available. The CBBA's inventory of more than 200,000 cord blood units and NMDP BioTherapies' cord unit search engine are utilized in the identification and provision of these units. This technology enables the quick identification of particular cord blood units that meet certain requirements.

Cord Blood Banking Services Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global cord blood banking services market, along with forecasts at the global, regional, and country levels from 2025-2033. The market has been categorized based on component, storage services, and application.

Analysis by Component:

• Cord Blood
• Cord Tissue

Cord blood stand as the largest component in 2024, holding around 62.5% of the market due to its rich source of hematopoietic stem cells (HSCs), which are widely used in treating genetic, blood, and immune disorders. Compared to cord tissue, cord blood is clinically approved for more medical applications, including lymphoma, leukemia, and sickle cell anemia. Its ease of collection, long-term cryopreservation capabilities, and lower risk of graft-versus-host disease (GVHD) make it preferable for transplantation. Additionally, increasing awareness of stem cell therapies, growing adoption of private cord blood banking, and expanding research in regenerative medicine further contribute to its market dominance

 Analysis by Storage Services:

• Public Cord Blood Banks
• Private Cord Blood Banks

Private cord blood banks lead the market with around 94.6% of the market share in 2024 due to the rising demand for personalized stem cell storage for future medical use. Parents prefer private banking for exclusive access to their child’s stem cells, ensuring availability for potential family treatments, including genetic and autoimmune diseases. The growing prevalence of chronic disorders, increasing awareness of regenerative medicine, and technological advancements in cryopreservation further drive demand. Private banks offer customized storage plans, advanced processing techniques, and long-term security, making them more attractive than public banks. Additionally, higher marketing efforts, financing options, and premium services boost their market dominance.

Analysis by Application:

• Cancer Disease
• Diabetes
• Blood Disease
• Immune Disorders
• Metabolic Disorders
• Others

Diabetes leads the market with around 28% of the market share in 2024 due to the growing prevalence of type 1 and type 2 diabetes globally and the potential of stem cell therapies in diabetes treatment. Cord blood-derived hematopoietic and mesenchymal stem cells (MSCs) are being researched for their ability to regenerate pancreatic beta cells, modulate immune responses, and reduce insulin dependence. Advances in regenerative medicine and clinical trials exploring stem cell-based diabetes treatments further drive demand. As diabetes cases continue to rise, parents are increasingly banking cord blood for potential future therapeutic use, strengthening its role in the market.

Regional Analysis:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

In 2024, North America accounted for the largest market share of over 33.8%. The cord blood banking services market in North America is driven by high awareness of stem cell therapies, increasing prevalence of genetic and autoimmune disorders, and strong government support for regenerative medicine. The region has a well-established healthcare infrastructure, advanced cryopreservation technologies, and stringent regulatory standards, ensuring high-quality storage. The growing adoption of private cord blood banking is fueled by rising disposable incomes and personalized medicine demand. Increasing investments in stem cell research, expanding clinical trials, and FDA approvals for new therapies further boost the market. Additionally, strategic partnerships between hospitals, research institutions, and biotechnology firms enhance service accessibility and innovation.

Key Regional Takeaways:

United States Cord Blood Banking Services Market Analysis

In 2024, the United States accounted for over 92.10% of the cord blood banking services market in North America. The U.S. cord blood banking services market is experiencing robust growth, driven by increasing awareness of the therapeutic potential of stem cells, rising healthcare expenditures, and the growing prevalence of chronic diseases. An estimated 129 Million people in the U.S. suffer from at least one major chronic disease, such as heart disease, cancer, diabetes, obesity, or hypertension, as defined by the U.S. Department of Health and Human Services. This widespread health burden has heightened the demand for innovative treatments, including stem cell therapies that utilize cord blood. Additionally, the expanding applications of stem cells in regenerative medicine and personalized healthcare further fuel the market's growth. The rising number of expectant parents opting for cord blood storage as a precautionary measure against future health issues also contributes to the market expansion. The availability of both private and public banking options, coupled with favorable government policies and reimbursement frameworks, has made these services more accessible. Increased public awareness, through educational campaigns and information-sharing, is further encouraging parents to preserve their newborn’s cord blood for potential medical use. Advancements in medical technologies and increasing research funding for stem cell treatments are expected to continue driving the demand for cord blood banking services in the U.S. over the coming years.

Asia Pacific Cord Blood Banking Services Market Analysis

The APAC cord blood banking market is expanding due to increasing awareness of stem cell therapies and a growing elderly population. According to reports, the number of older persons in Asia and the Pacific is projected to more than double, from 630 Million in 2020 to approximately 1.3 Billion by 2050. This demographic shift heightens the demand for healthcare solutions, including stem cell-based therapies. According to reports, in 2020, the cancer incidence in Asia was 169.1 per 100,000, accounting for 49.3% of global cancer cases, with lung, breast, and colorectal cancers being the most common. These rising cancer rates highlight the increasing need for stem cell treatments, contributing to the market’s growth. Additionally, improved healthcare infrastructure, rising disposable incomes in emerging markets, and government initiatives promoting stem cell research and education about its benefits are accelerating the adoption of cord blood banking services across the region.

Europe Cord Blood Banking Services Market Analysis

The European cord blood banking market benefits from increasing awareness of stem cell therapies and rising healthcare investments. According to reports, on 1 January 2023, the EU population was estimated at 448.8 Million, with more than one-fifth (21.3%) aged 65 years and over. This aging demographic creates a growing demand for stem cell treatments, particularly for age-related diseases such as cancer and cardiovascular conditions. The increasing prevalence of chronic diseases among the elderly further fuels the need for stem cell therapies. Additionally, according to technological advancements in cord blood processing, such as automated systems for better quality and efficient storage, the market is positioned for growth. Public and private sector initiatives, including government-sponsored cord blood banks and collaborations between healthcare institutions, enhance access to cord blood banking services across the region. Furthermore, according to the EU's strong regulatory framework and commitment to healthcare innovation, the market is receiving substantial support. With rising public awareness of the benefits of preserving cord blood and its therapeutic potential, there is an increasing willingness to invest in private cord blood banks. As personalized medicine continues to gain momentum, Europeans are increasingly recognizing the long-term value of cord blood in combating a variety of diseases, positioning the market for sustained growth.

Latin America Cord Blood Banking Services Market Analysis

In Latin America, demand for cord blood banking services is growing due to improving healthcare access and awareness of stem cell therapies. According to reports, in Brazil, chronic diseases are expected to cause 928,000 deaths annually, emphasizing the need for stem cell treatments. Governments are increasingly supporting stem cell research, which bolsters market adoption. Additionally, according to rising economic growth and public-private healthcare partnerships, the cord blood banking market is expanding across the region. This growing focus on personalized medicine further drives interest in preserving cord blood for future therapeutic use.

Middle East and Africa Cord Blood Banking Services Market Analysis

In the Middle East and Africa, cord blood banking services are gaining traction, driven by rising awareness of stem cell treatments and healthcare improvements. It has been reported that in 2021, a total of 154 children aged 0–14 years were diagnosed with new invasive cases of cancer across the UAE. These chronic conditions drive demand for stem cell therapies. According to government policies supporting healthcare advancements and research, the market for cord blood banking is expanding. Enhanced healthcare infrastructure and increasing investments in medical research further support this growing market.

Competitive Landscape:

The cord blood banking services market is competitive, with key players focusing on technological advancements, strategic partnerships, and service expansion. Major companies include Cord Blood Registry (CBR), Cryo-Cell International, ViaCord, and Global Cord Blood Corporation, competing through storage innovations, pricing strategies, and regulatory compliance. The market is segmented into public and private banks, with private banks gaining traction due to personalized storage services. Companies are investing in R&D for regenerative medicine applications and expanding into emerging markets. Government initiatives, accreditation standards, and rising consumer awareness drive competition, while mergers and acquisitions further consolidate industry presence among leading providers.

The report provides a comprehensive analysis of the competitive landscape in the cord blood banking services market with detailed profiles of all major companies, including:

• Alphacord LLC
• Americord Registry LLC
• ATCC
• California Cryobank
• Cordlife Group Limited
• Cryo-Cell International Inc.
• Global Cord Blood Corporation
• LifeBank
• LifeCell International Pvt. Ltd.
• National Cord Blood Program
• Norton Healthcare Inc.
• Perkinelmer Inc.
• StemCyte India Therapeutics Pvt. Ltd.

Latest News and Developments:

• November 2024: Sidra Medicine, part of Qatar Foundation, has launched Qatar’s first local cord blood banking service, allowing families to store their newborns’ stem cells for potential future medical use. The procedure, which involves collecting and storing blood from the umbilical cord and placenta, is painless and safe for both the mother and the kid. Hematopoietic stem cells found in cord blood have the potential to treat a wide range of ailments, including malignancies, blood problems, and immune system diseases.
• September 2024: Cordlife Group, along with its subsidiaries, has been approved to resume cord blood banking in Singapore under controlled conditions. The company has introduced an enhanced processing and storage facility, featuring improved operational protocols and an advanced laboratory monitoring system.
• May 2024: The Department of Health – Abu Dhabi (DoH) and M42 have partnered to launch the Abu Dhabi Biobank, including the region’s largest hybrid cord blood bank. Announced at the Abu Dhabi Global Healthcare Week 2024, the initiative aims to improve treatment access, reduce waiting times, and enhance patient survival rates. The Biobank is a key element of Abu Dhabi’s vision to become a global biobanking hub, supporting medical research, drug discovery, and personalized healthcare.
• May 2024: StemCyte renewed its partnership with the California State Umbilical Cord Blood Collection Program (CA-UCBCP) and UC Davis Health. This collaboration enhances StemCyte's focus on ethnic diversity in cord blood banking, having banked thousands of units from Latino, Asian, and African American communities since 2013. The renewed contract includes additional funding to diversify the National Marrow Donor Program (NMDP) registry and plans for new hospital collecting sites in Palm Springs and Sacramento.
• February 2023: Cordlife Group Limited, a leading provider of cord blood banking services listed on the Singapore Exchange, launched its peripheral blood stem cell (PBSC) processing and storage service in Singapore. The Centre for Clinical Haematology (CFCH) became Cordlife’s first partner, offering the service to patients needing stem cell transplants for blood cancers and other blood disorders. PBSC, a source of haematopoietic stem cells (HSC), was used in transplants to treat conditions like leukaemia, lymphoma, and myeloma.

Cord Blood Banking Services Market Report Scope:

Key Benefits for Stakeholders:

• IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the cord blood banking services market from 2019-2033.
• The research study provides the latest information on the market drivers, challenges, and opportunities in the global cord blood banking services market.
• The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
• Porter's Five Forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the cord blood banking services industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.